CD4 and systemic lupus erythematosus: Based on therapeutic effects of the combination of metformin and 2DG in lupus mouse models that normalized the expansion of effector CD4+ T cells (3, 8), we hypothesized that these metabolic inhibitors would also have a beneficial effect in autoimmune arthritis.